Doctor of Philosophy, The Ohio State University, 2016, Molecular, Cellular and Developmental Biology
Vitamin D, the precursor to the potent steroid hormone calcitriol (1,25(OH)2D), is obtained through synthesis following sunlight exposure, diet and supplements. Vitamin D is first metabolized by CYP2R1 in the liver to produce calcifediol (25(OH)D), a circulating form of vitamin D, which is further converted to 1,25(OH)2D by CYP27B1 primarily in the kidney. 1,25(OH)2D can also be produced by extrarenal CYP27B1 in local tissues, including the breast, functioning in an intracrine, autocrine or paracrine manner. 1,25(OH)2D binds to the vitamin D receptor (VDR) that regulates multiple gene expression. However, most studies reported circulating 25(OH)D level but not the level of 1,25(OH)2D in the target tissue. Laboratory studies indicate that vitamin D should decrease the risk of breast cancer, although epidemiological studies are mixed. Thus, the potential anticancer mechanisms for women remain elusive. In the breast, little is known about the metabolic consequences of vitamin D at the cellular level and how this may potentially impact early breast carcinogenesis. In order to address these issues, blood and tissue samples from 153 healthy women undergoing reduction mammoplasty were used to examine 25(OH)D, 1,25(OH)2D levels and VDR protein expression. These women never had cancer, so findings from their breast tissue would represent biological processes before cancer develops, e.g. early carcinogenesis. I aimed to assess the correlation of blood to breast vitamin D levels, to assess the usefulness of blood levels of 25(OH)D in epidemiology studies as markers for breast levels of 1,25(OH)2D (aim 1), and if there were breast cancer risk factors that affected breast vitamin D levels (aim 2) (Fig. 1.4). I also aimed to determine if there were breast VDR (receptor) that positively correlated to 1,25(OH)2D and 25(OH)D (ligands) (aim 3). To investigate if breast vitamin D alone or with VDR affected breast pre-carcinogenesis, different markers were determined in normal breast (open full item for complete abstract)
Committee: Peter Shields (Advisor); Jeffrey Parvin (Committee Member); Gregory Lesinski (Committee Member); Michael Freitas (Committee Member)
Subjects: Biomedical Research; Biostatistics; Endocrinology; Epidemiology; Molecular Biology; Oncology; Womens Studies